Data Sheet

MSDS

Ginsenoside F4 [CAS 181225-33-2]

CAS No:	181225-33-2
Applications:	COVID-19-immunoregulation
MW:	767.00
Formula:	C₄₂H₇₀O₁₂
SMILES:	C[C@]12[C@]3([C@@]([C@H](O)C[C@]1([H])[C@@]4([C@@](C(C)([C@@H](O)CC4)C)([H])[C@@H](O[C@@]5([H])[C@@H]([C@H]([C@H](O)[C@@H](CO)O5)O)O[C@@]6([H])[C@@H]([C@@H]([C@@H](O)[C@H](C)O6)O)O)C2)C)([H])[C@@H](/C(C)=C/C/C=C(C)/C)CC3)C
Purity:	98.35
Description:	Ginsenoside F4 (GF4), ginseng saponinis, isolated from notoginseng or red ginseng. Ginsenoside F4 (GF4) has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis[1].Ginsenoside F4 (GF4) inhibits matrix metalloproteinase 13 (MMP 13) expression in IL-1?-treated chondrocytes and blocks cartilage breakdown in rabbit cartilage tissue culture, shows therapeutic potential for preventing cartilage collagen matrix breakdown in diseased tissues[2].
Shipping Conditions:	Ship at ambient
Usage:	Research Use Only